Arcellx Ownership

ACLX Stock  USD 71.31  1.04  1.48%   
The majority of Arcellx outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Arcellx to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Arcellx. Please pay attention to any change in the institutional holdings of Arcellx as this could imply that something significant has changed or is about to change at the company.
Some institutional investors establish a significant position in stocks such as Arcellx in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Arcellx, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arcellx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Arcellx Stock please use our How to Invest in Arcellx guide.

Arcellx Stock Ownership Analysis

About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.99. Arcellx had not issued any dividends in recent years. Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. Arcellx, Inc. was incorporated in 2014 and is headquartered in Gaithersburg, Maryland. Arcellx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 78 people. For more info on Arcellx please contact Rami Elghandour at 240 327 0630 or go to https://www.arcellx.com.
Besides selling stocks to institutional investors, Arcellx also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Arcellx's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Arcellx's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Arcellx Quarterly Liabilities And Stockholders Equity

648.08 Million

Arcellx Insider Trades History

About 15.0% of Arcellx are currently held by insiders. Unlike Arcellx's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Arcellx's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Arcellx's insider trades
 
Covid

Arcellx Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Arcellx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arcellx backward and forwards among themselves. Arcellx's institutional investor refers to the entity that pools money to purchase Arcellx's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
T. Rowe Price Investment Management,inc.2025-03-31
1.7 M
Hhg Plc2025-03-31
1.5 M
Cormorant Asset Management, Llc2025-03-31
1.1 M
Aju Ib Investment Co Ltd2025-06-30
M
Geode Capital Management, Llc2025-03-31
M
Citadel Advisors Llc2025-03-31
726.1 K
Capital World Investors2025-03-31
709.4 K
Jpmorgan Chase & Co2025-03-31
683.6 K
Lord, Abbett & Co Llc2025-03-31
664.5 K
Fmr Inc2025-03-31
6.3 M
Paradigm Biocapital Advisors Lp2025-03-31
4.5 M
Note, although Arcellx's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Arcellx Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Arcellx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Arcellx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Arcellx insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Arcellx Outstanding Bonds

Arcellx issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Arcellx uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Arcellx bonds can be classified according to their maturity, which is the date when Arcellx has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Arcellx Corporate Filings

F4
11th of June 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
28th of May 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
15th of May 2025
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Arcellx Stock Analysis

When running Arcellx's price analysis, check to measure Arcellx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcellx is operating at the current time. Most of Arcellx's value examination focuses on studying past and present price action to predict the probability of Arcellx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcellx's price. Additionally, you may evaluate how the addition of Arcellx to your portfolios can decrease your overall portfolio volatility.